Secretory Interleukin-1 Receptor Antagonist Gene Expression Requires both a PU.1 and a Novel Composite NF-κB/PU.1/ GA-binding Protein Binding Site

作者: Michael F. Smith , Virginia S. Carl , Tracey Lodie , Matthew J. Fenton

DOI: 10.1074/JBC.273.37.24272

关键词:

摘要: Abstract The human secretory interleukin-1 receptor antagonist (secretory IL-1Ra) gene is controlled through three lipopolysaccharide (LPS)-responsive promoter elements, one of which was identified as an NF-κB binding site. Sequence analysis the IL-1Ra a potential PU.1 site located between positions −80 and −90 on complementary strand overlapping Gel shift using this with nuclear extracts from RAW 264.7 macrophages demonstrated formation complexes, LPS-inducible two constitutive. inducible factor NF-κB, constitutive factors were GA-binding protein. Site-directed mutagenesis −93 to −79 region that mutation either 5′-half or PU.1/GA-binding protein half-site alone did not significantly decrease LPS responsiveness. However, disrupted all resulted in 50% A second centered at −230 by gel supershift assays. Mutation core GGAA LPS-responsive activity. both distal proximal response elements led almost complete loss These data therefore suggest regulation expression complex event involving interactions different transcription single cis-acting element sites are major for LPS-induced expression.

参考文章(53)
W P Arend, C H Hannum, R C Thompson, F G Joslin, An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. Journal of Immunology. ,vol. 143, pp. 1851- 1858 ,(1989)
D.J. Dripps, B.J. Brandhuber, R.C. Thompson, S.P. Eisenberg, Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. Journal of Biological Chemistry. ,vol. 266, pp. 10331- 10336 ,(1991) , 10.1016/S0021-9258(18)99230-6
E.V. Granowitz, B.D. Clark, J. Mancilla, C.A. Dinarello, Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. Journal of Biological Chemistry. ,vol. 266, pp. 14147- 14150 ,(1991) , 10.1016/S0021-9258(18)98655-2
W P Arend, J K Jenkins, M F Smith, M E Shuck, R F Drong, J L Slightom, M J Bienkowski, Intracellular IL-1 receptor antagonist promoter: cell type-specific and inducible regulatory regions. Journal of Immunology. ,vol. 158, pp. 748- 755 ,(1997)
R Shackelford, S P Johnson, D O Adams, IFN-gamma and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. Journal of Immunology. ,vol. 154, pp. 1374- 1382 ,(1995)
CA Dinarello, Interleukin-1 and interleukin-1 antagonism. Blood. ,vol. 77, pp. 1627- 1652 ,(1991) , 10.1182/BLOOD.V77.8.1627.1627
A Gutierrez-Hartmann, W P Arend, M F Smith, D Eidlen, LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. Journal of Immunology. ,vol. 153, pp. 3584- 3593 ,(1994)
H.L. Pahl, R.J. Scheibe, D.E. Zhang, H.M. Chen, D.L. Galson, R.A. Maki, D.G. Tenen, The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. Journal of Biological Chemistry. ,vol. 268, pp. 5014- 5020 ,(1993) , 10.1016/S0021-9258(18)53496-7
A Gutierrez-Hartmann, W P Arend, M F Smith, D Eidlen, S P Eisenberg, M T Brewer, Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions. Journal of Immunology. ,vol. 149, pp. 2000- 2007 ,(1992)
Matthew J. Sweet, David A. Hume, Endotoxin signal transduction in macrophages Journal of Leukocyte Biology. ,vol. 60, pp. 8- 26 ,(1996) , 10.1002/JLB.60.1.8